Observational studies of drugs and mortality. Ray WA (2005) N Engl J Med 353: 2319-21 Atypical antipsychotic drugs and the risk of sudden cardiac death. Ray WA, Chung CP, Murray KT, Hall K, Stein CM (2009) N Engl J Med 360: 225-35 Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy. Ray WA, Daugherty JR, Meador KG (2003) N Engl J Med 348: 1885-94 Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, Douglas IS, Malhotra A, Owens RL, Feinstein DJ, Khan B, Pisani MA, Hyzy RC, Schmidt GA, Schweickert WD, Hite RD, Bowton DL, Masica AL, Thompson JL, Chandrasekhar R, Pun BT, Strength C, Boehm LM, Jackson JC, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Bernard GR, Dittus RS, Ely EW, MIND-USA Investigators (2018) N Engl J Med 379: 2506-2516 A randomized trial of a consultation service to reduce falls in nursing homes. Ray WA, Taylor JA, Meador KG, Thapa PB, Brown AK, Kajihara HK, Davis C, Gideon P, Griffin MR (1997) JAMA 278: 557-62 Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG (2008) Pharmacol Rev 60: 358-403 Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents. Rook JM, Xiang Z, Lv X, Ghoshal A, Dickerson JW, Bridges TM, Johnson KA, Foster DJ, Gregory KJ, Vinson PN, Thompson AD, Byun N, Collier RL, Bubser M, Nedelcovych MT, Gould RW, Stauffer SR, Daniels JS, Niswender CM, Lavreysen H, Mackie C, Conde-Ceide S, Alcazar J, Bartolomé-Nebreda JM, Macdonald GJ, Talpos JC, Steckler T, Jones CK, Lindsley CW, Conn PJ (2015) Neuron 86: 1029-1040 Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release. Foster DJ, Wilson JM, Remke DH, Mahmood MS, Uddin MJ, Wess J, Patel S, Marnett LJ, Niswender CM, Jones CK, Xiang Z, Lindsley CW, Rook JM, Conn PJ (2016) Neuron 91: 1244-1252 Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P (2000) Neuron 28: 53-67 Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Hashimoto T, Arion D, Unger T, Maldonado-Avilés JG, Morris HM, Volk DW, Mirnics K, Lewis DA (2008) Mol Psychiatry 13: 147-61 Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Albaugh VL, Judson JG, She P, Lang CH, Maresca KP, Joyal JL, Lynch CJ (2011) Mol Psychiatry 16: 569-81 Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P (2001) Mol Psychiatry 6: 293-301 Activation of the mGlu metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M muscarinic receptor allosteric modulators. Yohn SE, Foster DJ, Covey DP, Moehle MS, Galbraith J, Garcia-Barrantes PM, Cho HP, Bubser M, Blobaum AL, Joffe ME, Cheer JF, Jones CK, Lindsley CW, Conn PJ (2020) Mol Psychiatry 25: 2786-2799 Altered brain activation during action imitation and observation in schizophrenia: a translational approach to investigating social dysfunction in schizophrenia. Thakkar KN, Peterman JS, Park S (2014) Am J Psychiatry 171: 539-48 The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes. Behr ER, January C, Schulze-Bahr E, Grace AA, Kääb S, Fiszman M, Gathers S, Buckman S, Youssef A, Pirmohamed M, Roden D (2013) Eur Heart J 34: 1958-63 Antipsychotics and the risk of sudden cardiac death. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT (2001) Arch Gen Psychiatry 58: 1161-7 Neurotensin-deficient mice show altered responses to antipsychotic drugs. Dobner PR, Fadel J, Deitemeyer N, Carraway RE, Deutch AY (2001) Proc Natl Acad Sci U S A 98: 8048-53 Cognition, schizophrenia, and the atypical antipsychotic drugs. Meltzer HY, Park S, Kessler R (1999) Proc Natl Acad Sci U S A 96: 13591-3 Targeting glutamate synapses in schizophrenia. Field JR, Walker AG, Conn PJ (2011) Trends Mol Med 17: 689-98 Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Conn PJ, Jones CK, Lindsley CW (2009) Trends Pharmacol Sci 30: 148-55 Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. MacDonald ML, Eaton ME, Dudman JT, Konradi C (2005) Biol Psychiatry 57: 1041-51 Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia. Pongrac JL, Middleton FA, Peng L, Lewis DA, Levitt P, Mirnics K (2004) Biol Psychiatry 56: 943-50 Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Konradi C, Heckers S (2001) Biol Psychiatry 50: 729-42 Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K (2007) Biol Psychiatry 62: 711-21 Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings. Conn PJ, Roth BL (2008) Neuropsychopharmacology 33: 2048-60 Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Byun NE, Grannan M, Bubser M, Barry RL, Thompson A, Rosanelli J, Gowrishankar R, Kelm ND, Damon S, Bridges TM, Melancon BJ, Tarr JC, Brogan JT, Avison MJ, Deutch AY, Wess J, Wood MR, Lindsley CW, Gore JC, Conn PJ, Jones CK (2014) Neuropsychopharmacology 39: 1578-93 RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E (2001) Neuropsychopharmacology 24: 478-91 Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Wang HD, Dunnavant FD, Jarman T, Deutch AY (2004) Neuropsychopharmacology 29: 1230-8 Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model. Ghoshal A, Rook JM, Dickerson JW, Roop GN, Morrison RD, Jalan-Sakrikar N, Lamsal A, Noetzel MJ, Poslusney MS, Wood MR, Melancon BJ, Stauffer SR, Xiang Z, Daniels JS, Niswender CM, Jones CK, Lindsley CW, Conn PJ (2016) Neuropsychopharmacology 41: 598-610 The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat. Petrie KA, Bubser M, Casey CD, Davis MD, Roth BL, Deutch AY (2004) Neuropsychopharmacology 29: 1878-88 Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol. Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY (2005) Neuropsychopharmacology 30: 2283-9 Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. Wang HD, Deutch AY (2008) Neuropsychopharmacology 33: 1276-86 Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine. Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY (2006) Neuropsychopharmacology 31: 1991-2001 Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Albaugh VL, Vary TC, Ilkayeva O, Wenner BR, Maresca KP, Joyal JL, Breazeale S, Elich TD, Lang CH, Lynch CJ (2012) Schizophr Bull 38: 153-66 Gesture imitation in schizophrenia. Matthews N, Gold BJ, Sekuler R, Park S (2013) Schizophr Bull 39: 94-101 Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Konradi C, Heckers S (2003) Pharmacol Ther 97: 153-79 Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. Fadel J, Bubser M, Deutch AY (2002) J Neurosci 22: 6742-6 Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. Bharadwaj R, Jiang Y, Mao W, Jakovcevski M, Dincer A, Krueger W, Garbett K, Whittle C, Tushir JS, Liu J, Sequeira A, Vawter MP, Gardner PD, Casaccia P, Rasmussen T, Bunney WE, Mirnics K, Futai K, Akbarian S (2013) J Neurosci 33: 11839-51 Intracellular modulation of NMDA receptor function by antipsychotic drugs. Leveque JC, Macías W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li XM, Coyle JT, Huganir RL, Heckers S, Konradi C (2000) J Neurosci 20: 4011-20 Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ (1995) J Neurosci 15: 2453-61
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.